CSIMarket Company Name, Ticker, Customers, else..


Contineum Therapeutics Inc   (CTNM)
Other Ticker:  
 


 

Contineum Therapeutics Inc

CTNM's Financial Statements and Analysis



Contineum Therapeutics Inc reported in the second quarter of 2024 net loss per share of $-0.39 compare to earnings per share of $0.00 in the same quarter a year ago and improved compare to net loss per share of $-3.55 realized in previous quarter.


second quarter of 2024
Earnings Per Share Revenues
$ -0.39 $  0 Mill
$-0.39     Unch.    



Contineum Therapeutics Inc 's Revenue rose by 0 % in second quarter of 2024 (Jun 30 2024) year on year, to $0 million and declined by sequentially.


Contineum Therapeutics Inc is Expected to report next financial results on May 15, 2025.

More on CTNM's Income Statement



Contineum Therapeutics Inc in the second quarter of 2024 recorded net loss of $-9.009 million, a decrease compare to net income of $0.000 million achieved in a year ago.

Sequentially net loss advanced

More on CTNM's Growth

Contineum Therapeutics Inc Inventories
CTNM's Cash flow In the second quarter of 2024 company's net cash flow was $61 million

More on CTNM's Cash flow Statement


Contineum Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Contineum Therapeutics Inc payed $ -0.71 cash per share, on a free-cash flow basis .

.


Company issued 20.99 million shares or 885.86 % in Jun 30 2024.


• More on CTNM's Dividends

 Market Capitalization (Millions) 421
 Shares Outstanding (Millions) 23
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -17
 Cash Flow (TTM) (Millions $) 62
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Contineum Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Contineum Therapeutics Inc had negative $ -0.71 cash flow per share, on a free-cash flow basis .

.


Company issued 20.99 million shares or 885.86 % in Jun 30 2024.


• More on CTNM's Balance Sheets

 Market Capitalization (Millions) 421
 Shares Outstanding (Millions) 23
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -17
 Cash Flow (TTM) (Millions $) 62
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Contineum Therapeutics Inc Earnings